Literature DB >> 20428909

Mucositis does not lead to false-positivity of the Platelia Aspergillus enzyme-linked immunosorbent assay.

Z Racil1, I Kocmanova, B Weinbergerova, M Toskova, J Winterova, M Lengerova, L Buresova, S Timilsina, J Mayer.   

Abstract

We are reporting a study evaluating the crossover of antigens reacting in Platelia Aspergillus (PA) enzyme-linked immunosorbent assay (ELISA) from faeces to vessels during mucositis as a possible cause of false-positivity of this test. In our series of 102 episodes of different grades of mucositis, we found strong reactivity of faeces in the PA ELISA test irrespective of the grade of mucositis, the percentage of oral food intake or the presence of total parenteral nutrition. However, none of the patients included in the study were positive in the serum (when the criterion of two samples with cut-off index of positivity [IP] > 0.5 was used).

Entities:  

Mesh:

Year:  2010        PMID: 20428909     DOI: 10.1007/s10096-010-0938-7

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  10 in total

1.  Use of circulating galactomannan screening for early diagnosis of invasive aspergillosis in allogeneic stem cell transplant recipients.

Authors:  Johan Maertens; Johan Van Eldere; Jan Verhaegen; Erik Verbeken; Johny Verschakelen; Marc Boogaerts
Journal:  J Infect Dis       Date:  2002-10-08       Impact factor: 5.226

2.  Aspergillus galactomannan antigen levels in allogeneic haematopoietic stem cell transplant recipients given total parenteral nutrition.

Authors:  N M A Blijlevens; J P Donnelly; J F G M Meis; P E Verweij; B E de Pauw
Journal:  Transpl Infect Dis       Date:  2002-06       Impact factor: 2.228

Review 3.  Detection of circulating galactomannan for the diagnosis and management of invasive aspergillosis.

Authors:  Monique A S H Mennink-Kersten; J Peter Donnelly; Paul E Verweij
Journal:  Lancet Infect Dis       Date:  2004-06       Impact factor: 25.071

4.  Intravenous PLASMA-LYTE as a major cause of false-positive results of platelia Aspergillus test for galactomannan detection in serum.

Authors:  Zdenek Racil; Iva Kocmanova; Martina Lengerova; Jana Winterova; Jiri Mayer
Journal:  J Clin Microbiol       Date:  2007-08-01       Impact factor: 5.948

5.  Bifidobacterial lipoglycan as a new cause for false-positive platelia Aspergillus enzyme-linked immunosorbent assay reactivity.

Authors:  Monique A S H Mennink-Kersten; Dorien Ruegebrink; Rocus R Klont; Adilia Warris; Françoise Gavini; Huub J M Op den Camp; Paul E Verweij
Journal:  J Clin Microbiol       Date:  2005-08       Impact factor: 5.948

6.  Aspergillus galactomannan detection in the diagnosis of invasive aspergillosis in cancer patients.

Authors:  Raoul Herbrecht; Valérie Letscher-Bru; Corina Oprea; Bruno Lioure; Jocelyn Waller; France Campos; Odile Villard; Kun-Lun Liu; Shanti Natarajan-Amé; Patrick Lutz; Patrick Dufour; Jean-Pierre Bergerat; Ermanno Candolfi
Journal:  J Clin Oncol       Date:  2002-04-01       Impact factor: 44.544

7.  Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus.

Authors:  S Ascioglu; J H Rex; B de Pauw; J E Bennett; J Bille; F Crokaert; D W Denning; J P Donnelly; J E Edwards; Z Erjavec; D Fiere; O Lortholary; J Maertens; J F Meis; T F Patterson; J Ritter; D Selleslag; P M Shah; D A Stevens; T J Walsh
Journal:  Clin Infect Dis       Date:  2001-11-26       Impact factor: 9.079

8.  Detection of Aspergillus galactomannan antigen in foods and antibiotics.

Authors:  R Ansorg; R van den Boom; P M Rath
Journal:  Mycoses       Date:  1997-12       Impact factor: 4.377

9.  Diagnosis of invasive aspergillosis using a galactomannan assay: a meta-analysis.

Authors:  Christopher D Pfeiffer; Jason P Fine; Nasia Safdar
Journal:  Clin Infect Dis       Date:  2006-04-14       Impact factor: 9.079

10.  Detection of galactomannan antigenemia in patients receiving piperacillin-tazobactam and correlations between in vitro, in vivo, and clinical properties of the drug-antigen interaction.

Authors:  Thomas J Walsh; Shmuel Shoham; Ruta Petraitiene; Tin Sein; Robert Schaufele; Amy Kelaher; Heidi Murray; Christine Mya-San; John Bacher; Vidmantas Petraitis
Journal:  J Clin Microbiol       Date:  2004-10       Impact factor: 5.948

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.